A Novel Replication Competent Flavivirus-based HIV Vaccine Platform ie RepliVax as a Priming Component for Improving Antibody Response

Medicine & Life Sciences

1. AIDS Vaccines 100%
2. Flavivirus 98%
3. Antibody Formation 69%
4. env Gene Products 46%
5. AIDSVAX 40%
6. erdosteine 39%
7. Vaccines 33%
8. Primates 30%
9. Immunization 27%
10. Preliminary Data 23%
11. AIDSVAX B-E 21%
12. HIV Infections 19%
13. Immunoglobulin G 16%
14. HIV Antigens 16%
15. Infections 15%
16. Poxviridae 15%
17. aluminum sulfate 14%
18. Program Development 13%
19. Psychological Identification 13%
20. Blocking Antibodies 13%
21. Antibodies 12%
22. Proteins 12%
23. Virus Replication 11%
24. Mental Competency 10%
25. Case-Control Studies 8%
26. Antigens 6%
27. T-Lymphocytes 6%